Loading...

Switching to SAR in TCZ nonresponders may have favorable efficacy outcomes in RA

2 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 3, 2018

Dr. Jack Cush of Baylor Research Institute and Dr. Arthur Kavanaugh of University of California, San Diego look at the latest developments in rheumatoid arthritis for 2018

Comments are disabled for this video.

to add this to Watch Later

Add to

Loading playlists...